Aquestive Therapeutics Inc has a consensus price target of $8.5, established from looking at the 29 latest analyst ratings. The last 3 analyst ratings were released from Leerink Partners, HC Wainwright & Co., and HC Wainwright & Co. on May 10, 2024, May 9, 2024, and April 30, 2024. With an average price target of $8.67 between Leerink Partners, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 179.57% upside for Aquestive Therapeutics Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by Leerink Partners on May 10, 2024. The analyst firm set a price target for $8.00 expecting AQST to rise to within 12 months (a possible 158.06% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Aquestive Therapeutics (NASDAQ: AQST) was provided by Leerink Partners, and Aquestive Therapeutics initiated their outperform rating.
The last upgrade for Aquestive Therapeutics Inc happened on March 9, 2023 when Wedbush raised their price target to $4. Wedbush previously had a neutral for Aquestive Therapeutics Inc.
There is no last downgrade for Aquestive Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aquestive Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aquestive Therapeutics was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
While ratings are subjective and will change, the latest Aquestive Therapeutics (AQST) rating was a initiated with a price target of $0.00 to $8.00. The current price Aquestive Therapeutics (AQST) is trading at is $3.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.